Lymphomatoid Papulosis
📧 Sign up to get email alerts when something new happens for Lymphomatoid Papulosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin in combination with Lenalidomide for relapsed or refractory T-cell lymphoma including cutaneous…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients [Phase 2]
A Phase 2 trial update describes dosing of Brentuximab Vedotin for patients with Mycosis fungoides and Sézary syndrome, with lymphomatoid pa…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) [Phase 2]
Phase 2 clinical trial update for brentuximab vedotin (SGN-35) in CD30-positive lymphoproliferative disorders, including primary cutaneous a…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma [Phase 2]
A Phase 2 study evaluating brentuximab vedotin in combination with lenalidomide for stage IB-IVB relapsed or refractory T-cell lymphoma has …